270 results on '"Julie Park"'
Search Results
202. G-CSF Is a Cancer Stem Cell–Specific Growth Factor—Letter
- Author
-
Julie Park, Jason R. Healy, Ruth Ladenstein, Ulrike Pötschger, and John M. Maris
- Subjects
Neuroblastoma cell ,Specific growth ,Cancer Research ,Oncology ,Cancer stem cell ,Neuroblastoma ,Immunology ,medicine ,STAT3 Transcription Factor ,Biology ,medicine.disease ,Granulocyte colony-stimulating factor - Abstract
We read with interest the recent article by Agarwal and colleagues investigating the biologic significance of granulocyte colony stimulating factor (G-CSF) in stem-like subpopulations of neuroblastoma cells ([1][1]). While we find their observations provocative, and do not debate their demonstration
- Published
- 2015
203. Book Reviews
- Author
-
Julie Park
- Published
- 2014
204. Editorial
- Author
-
Julie Park
- Published
- 2014
205. Healthcare-seeking behaviour of primary caregivers for acute otitis media in children aged 6 months to <30 months in Panama: results of a cross-sectional survey.
- Author
-
Villarreal, Iris, Turner, Rosario, Hyejin Jo, Julie Park, Gemmen, Eric, Pirçon, Jean-Yves, Castrejon, Maria M., Hausdorff, William P., Jo, Hyejin, and Park, Julie
- Subjects
ACUTE otitis media ,JUVENILE diseases ,MEDICAL care ,MEDICAL decision making ,OTITIS media treatment ,PSYCHOLOGY of caregivers ,COMPARATIVE studies ,RESEARCH methodology ,MEDICAL cooperation ,OTITIS media ,RESEARCH ,CITY dwellers ,EVALUATION research ,BURDEN of care ,DISEASE incidence ,CROSS-sectional method ,SEVERITY of illness index ,ACUTE diseases ,PATIENTS' attitudes - Abstract
Background: Acute otitis media (AOM) is the most common bacterial childhood infection. However, caregivers with children having mild episodes often do not seek healthcare services, which may lead to an under-appreciation of the disease experienced by the community. The objectives of this survey were to estimate the proportion of primary caregivers who went to a healthcare facility when they suspected that their child aged 6 to <30 months was having an AOM episode during the past 6 months and to assess what factors influenced their decision.Methods: This observational, cross-sectional survey of primary caregivers (≥18 years), with at least one child aged 6 to <30 months was performed in 19 healthcare facilities in Panama (March to May 2013). A 28-item paper questionnaire was administered to assess demographic data, AOM symptoms, as well as potential healthcare-seeking behaviour and factors influencing this behaviour. Potential confounding effects were individually assessed using Chi-squared or Cochran-Mantel-Haenszel tests, and all together in logistic regression models.Results: The total number of eligible participants was 1330 (mean age 28.5 ± 8.0 years). Of these, 245 participants had at least one child whom they suspected had an AOM episode during the past 6 months. Of the 245 participants, 213 (86.9%) sought healthcare at a facility. Several factors were associated with healthcare usage: perceived severity of illness (p = 0.001), occupational status of the caregiver (p = 0.002), household income (p = 0.016) and length of time since the last suspected AOM episode (p = 0.032).Conclusions: When confronted with a child with obvious symptoms of AOM, the majority of caregivers reported seeking healthcare. This behaviour appeared to be associated with factors related to the severity of the illness, the length of time since the last episode, as well as with the income and occupational status of the caregivers themselves. As many episodes of AOM present with non-specific respiratory symptoms, our results apply only to caregivers who were confronted with children with an obvious symptom. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
206. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)
- Author
-
Helen Conroy, Alain Charest, Julie Park, Elizabeth A. Preisinger, Keara Michelle Lane, David E. Housman, and Kevin McMahon
- Subjects
Cancer Research ,Reading Frames ,Oncogene Proteins, Fusion ,Molecular Sequence Data ,Tropomyosin receptor kinase B ,Biology ,Mitogen-activated protein kinase kinase ,Tropomyosin receptor kinase C ,Proto-Oncogene Mas ,Receptor tyrosine kinase ,Catalytic Domain ,Proto-Oncogene Proteins ,Chlorocebus aethiops ,Genetics ,Tumor Cells, Cultured ,Animals ,Humans ,Amino Acid Sequence ,Kinase activity ,Adaptor Proteins, Signal Transducing ,Orphan receptor ,Membrane Glycoproteins ,Base Sequence ,Chromosome Mapping ,Golgi Matrix Proteins ,Membrane Proteins ,Membrane Transport Proteins ,Receptor Protein-Tyrosine Kinases ,Protein-Tyrosine Kinases ,Molecular biology ,Fusion protein ,Molecular Weight ,Protein Biosynthesis ,ROR1 ,COS Cells ,biology.protein ,Chromosomes, Human, Pair 6 ,Chromosome Deletion ,Carrier Proteins ,Glioblastoma - Abstract
The transmembrane proto-oncogene receptor tyrosine kinase (RTK) ROS is an orphan receptor that is aberrantly expressed in neoplasms of the central nervous system. Here, we report the fusion of its carboxy-terminal kinase domain to the amino-terminal portion of a protein called FIG (Fused in Glioblastoma) in a human glioblastoma multiforme (GBM). By characterizing both FIG and ROS genes in normal and in U118MG GBM cells, we determined that an intra-chromosomal homozygous deletion of 240 kilobases on 6q21 is responsible for the formation of the FIG-ROS locus. The FIG-ROS transcript is encoded by 7 FIG exons and 9 ROS-derived exons. We also demonstrate that the FIG-ROS locus encodes for an in-frame fusion protein with a constitutively active kinase activity, suggesting that FIG-ROS may act as an oncogene. This is the first example of a fusion RTK protein that results from an intra-chromosomal deletion, and it represents the first fusion RTK protein isolated from a human astrocytoma.
- Published
- 2003
207. Inclusion of immigrant status in smoking prevalence statistics
- Author
-
Dowell Myers, Kaari F. Baluja, and Julie Park
- Subjects
Adult ,Male ,medicine.medical_specialty ,Letter ,Research and Practice ,Adolescent ,media_common.quotation_subject ,Immigration ,Health Behavior ,Ethnic group ,Pacific Islands ,Race (biology) ,Behavioral Risk Factor Surveillance System ,Risk-Taking ,Epidemiology ,Statistics ,medicine ,Ethnicity ,Prevalence ,Humans ,Risk factor ,media_common ,Aged ,Asian ,business.industry ,Public health ,Smoking ,Public Health, Environmental and Occupational Health ,Censuses ,Emigration and Immigration ,Middle Aged ,Health Surveys ,Pacific islanders ,Female ,business ,Demography - Abstract
Objectives. Data from the 1995–1996 and 1998–1999 Current Population Survey tobacco use supplements were used to examine smoking prevalence statistics by race/ethnicity and immigrant status. Methods. Smoking prevalence statistics were calculated, and these data were decomposed by country of birth for Asian immigrants to illustrate the heterogeneity in smoking rates present within racial/ethnic groups. Results. Except in the case of male Asian/Pacific Islanders, immigrants exhibited significantly lower smoking prevalence rates than nonimmigrants. However, rates varied according to country of birth. Conclusions. This research highlights the need to disaggregate health statistics by race/ethnicity, sex, immigrant status, and, among immigrants, country of birth. Data on immigrants’ health behaviors enhance the development of targeted and culturally sensitive public health smoking prevention programs.
- Published
- 2003
208. Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma
- Author
-
Julie Park, Kevin McMahon, David E. Housman, Cathy L. Nutt, Vicky Kheifets, Alan Charest, and Keara Michelle Lane
- Subjects
Oncogene Proteins ,Oncogene Proteins, Fusion ,Receptor Protein-Tyrosine Kinases ,Blotting, Western ,Golgi Apparatus ,Mice, Nude ,Receptor tyrosine kinase ,Cell Line ,symbols.namesake ,Mice ,Proto-Oncogene Proteins ,Tumor Cells, Cultured ,Animals ,Humans ,Protein Isoforms ,Phosphorylation ,Fluorescent Antibody Technique, Indirect ,Multidisciplinary ,biology ,Kinase ,Golgi apparatus ,Biological Sciences ,Protein-Tyrosine Kinases ,Fusion protein ,Precipitin Tests ,Protein Structure, Tertiary ,Rats ,Cell Transformation, Neoplastic ,Retroviridae ,Protein kinase domain ,Microscopy, Fluorescence ,Mutation ,symbols ,Cancer research ,biology.protein ,Chromosomes, Human, Pair 6 ,Glioblastoma ,Peptides ,Tyrosine kinase ,Ultracentrifugation ,Plasmids ,Subcellular Fractions - Abstract
Activating oncogenic mutations of receptor tyrosine kinases (RTKs) have been reported in several types of cancers. In many cases, genomic rearrangements lead to the fusion of unrelated genes to the DNA coding for the kinase domain of RTKs. All RTK-derived fusion proteins reported so far display oligomerization sequences within the 5′ fusion partners that are responsible for oncogenic activation. Here, we report a mechanism by which an altered RTK gains oncogenic potential in a glioblastoma cell line. A microdeletion on 6q21 results in the fusion of FIG , a gene coding for a Golgi apparatus-associated protein, to the kinase domain of the protooncogene c- ROS . The fused protein product FIG-ROS is a potent oncogene, and its transforming potential resides in its ability to interact with and become localized to the Golgi apparatus. Thus we have found a RTK fusion protein whose subcellular location leads to constitutive kinase activation and results in oncogenic transformation.
- Published
- 2003
209. Smelling the Difference: The Senses in Ethnic Conflict in West Kalimantan, Indonesia
- Author
-
Susanna Trnka, Christine Dureau, Julie Park, Koenig, Anika, Susanna Trnka, Christine Dureau, Julie Park, and Koenig, Anika
- Published
- 2013
210. Estimation of Housing Needs Amidst Population Growth and Change
- Author
-
Dowell Myers, Donald Pitkin, and Julie Park
- Subjects
Housing needs, Population growth, Homeownership, Household formation - Abstract
Housing needs is a concept of central importance to state and local planning in the United States (Landis and LeGates 2000). Roughly characterized as the number and type of housing units required to accommodate a population at a given standard of housing occupancy, the formulation of a quantified estimate of housing needs requires many assumptions that intertwine normative and empirical judgments. The overall aim of this article is to propose a needed theoretical framework and more rigorous methods for demographic component of housing needs estimates. Grounding this in the recent California experience helps to illustrate concepts with a concrete example. As demographic change continues to spread across the country, growing numbers of regions and cities can benefit from this study of the California experience. The article begins with a broad overview of the definition of housing needs, and then focuses on the central role of population growth and change in determining future construction needs. A pivotal issue is the instability over time of the empirical relationship between population and housing, as shown by comparison of household formation and homeownership rates from 1960 to 2000. A further issue is the sharp differences registered between different age groups, races, ethnicities, and nativity groups. Although disaggregation permits projections to capitalize on observed differences between groups, it also highlights the existence of inequities and the policy goal of reducing them.
- Published
- 2002
211. The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
- Author
-
Paul M. Trembling, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Julie Parkes, Andy Ryan, Sudeep Tanwar, Matthew Burnell, Scott Harris, Usha Menon, and William M. Rosenberg
- Subjects
Alcohol-related liver disease ,Non-alcoholic fatty liver disease ,Obesity ,Liver fibrosis ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Abstract Background Chronic liver disease (CLD) is usually asymptomatic but earlier detection is critical to permit life-saving interventions for those at risk due to high alcohol consumption and increased body mass index (BMI). The aim of this study was to estimate the association between the Enhanced Liver Fibrosis (ELF) test and liver-related events (LRE) and its performance in predicting LRE in postmenopausal women with risk factors in a nested case-control study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS). Methods In a cohort of 95,126 we performed a case-control study measuring ELF in blinded samples from 173 participants with self-reported high alcohol use and / or BMI ≥25 kg/m2 comprising all 58 cases who developed LRE and 115 controls matched for age, alcohol and BMI who did not develop LRE during median follow-up of 8.5 years. Results Using Cox regression at an ELF threshold of 10.51 hazard ratios (HR) for LRE were 4.88 (95% confidence interval (CI) 2.37–10.03) (unadjusted model) and 4.62 (95% CI 2.12–10.08) (adjusted for deprivation and self-reported hypertension, heart disease, hypercholesterolaemia and diabetes). At a threshold of 9.8 HR for LRE were 2.21 (95% CI 1.22–3.97) (unadjusted model) and 2.18 (95% CI 1.19–4.01) (adjusted). ELF was evaluated as a time dependent variable by generating time-dependent Cox models; HRs at an ELF threshold of 10.51 were 1.94 (95% CI 1.10–3.39) (unadjusted) and 2.05 (95% CI 1.16–3.64) (adjusted) and at a threshold of 9.8 HRs were 1.85 (95% CI 1.09–3.15) (unadjusted) and 1.80 (95% CI 1.04–3.13) (adjusted). Area under the receiver operating characteristic curve for recruitment ELF predicting LRE was 0.58 (95% CI 0.49–0.68), and for second subsequent ELF 0.61 (95% CI 0.52–0.71). Conclusion This study demonstrates the association between ELF and CLD in postmenopausal women with risk factors for liver disease, creating the opportunity to intervene to reduce liver-related mortality and morbidity. Although larger studies are required, these results demonstrate the potential of ELF as a prognostic tool in health checks in primary care. Trial registration This study is nested in UKCTOCS. UKCTOCS is registered as an International Standard Randomised Controlled Trial, number ISRCTN22488978 . Registered 06/04/2000.
- Published
- 2020
- Full Text
- View/download PDF
212. Determining the Prevalence and Incidence of SARS-CoV-2 Infection in Prisons in England: Protocol for a Repeated Panel Survey and Enhanced Outbreak Study
- Author
-
Emma Plugge, Danielle Burke, Maciej Czachorowski, Kerry Gutridge, Fiona Maxwell, Nuala McGrath, Oscar O'Mara, Eamonn O'Moore, and Julie Parkes
- Subjects
Medicine ,Computer applications to medicine. Medical informatics ,R858-859.7 - Abstract
BackgroundThere are over 80,000 people imprisoned in England and Wales in 117 prisons. The management of the COVID-19 pandemic presents particular challenges in this setting where confined, crowded, and poorly ventilated conditions facilitate the rapid spread of infectious diseases. ObjectiveThe COVID-19 in Prison Study aims to examine the epidemiology of SARS-CoV-2 in prisons in England in order to inform public health policy and practice during the pandemic and recovery. The primary objective is to estimate the proportion of positive tests of SARS-CoV-2 infection among residents and staff within selected prisons. The secondary objectives include estimating the incidence rate of SARS-CoV-2 infection and examining how the proportion of positive tests and the incidence rate vary among individual, institutional, and system level factors. MethodsPhase 1 comprises a repeated panel survey of prison residents and staff in a representative sample of 28 prisons across England. All residents and staff in the study prisons are eligible for inclusion. Participants will be tested for SARS-CoV-2 using a nasopharyngeal swab twice (6 weeks apart). Staff will also be tested for antibodies to SARS-CoV-2. Phase 2 focuses on SARS-CoV-2 infection in prisons with recognized COVID-19 outbreaks. Any prison in England will be eligible to participate if an outbreak is declared. In 3 outbreak prisons, all participating staff and residents will be tested for SARS-CoV-2 antigens at the following 3 timepoints: as soon as possible after the outbreak is declared (day 0), 7 days later (day 7), and at day 28. They will be swabbed twice (a nasal swab for lateral flow device testing and a nasopharyngeal swab for polymerase chain reaction testing). Testing will be done by external contractors. Data will also be collected on individual, prison level, and community factors. Data will be stored and handled at the University of Southampton and Public Health England. Summary statistics will summarize the prison and participant characteristics. For the primary objective, simple proportions of individuals testing positive for SARS-CoV-2 and incidence rates will be calculated. Linear regression will examine the individual, institutional, system, and community factors associated with SARS-CoV-2 infection within prisons. ResultsThe UK Government’s Department for Health and Social Care funds the study. Data collection started on July 20, 2020, and will end on May 31, 2021. As of May 2021, we had enrolled 4192 staff members and 6496 imprisoned people in the study. Data analysis has started, and we expect to publish the initial findings in summer/autumn 2021. The main ethical consideration is the inclusion of prisoners, who are vulnerable participants. ConclusionsThis study will provide unique data to inform the public health management of SARS-CoV-2 in prisons. Its findings will be of relevance to health policy makers and practitioners working in prisons. International Registered Report Identifier (IRRID)DERR1-10.2196/30749
- Published
- 2022
- Full Text
- View/download PDF
213. Infant care practices in New Zealand: a cross-cultural qualitative study
- Author
-
Michele Lennan, Sally Abel, Julie Park, David Tipene-Leach, and Sitaleki A Finau
- Subjects
Cross-Cultural Comparison ,Health (social science) ,Native Hawaiian or Other Pacific Islander ,Family support ,Culture ,Breastfeeding ,Ethnic group ,Pacific Islands ,Developmental psychology ,History and Philosophy of Science ,Ethnicity ,Medicine ,Humans ,Parenting ,business.industry ,Infant Care ,Infant, Newborn ,Infant ,Social Support ,Gender studies ,Focus Groups ,Focus group ,language.human_language ,Europe ,Breast Feeding ,language ,Sociology of health and illness ,Samoan ,business ,Sleep ,Breast feeding ,New Zealand - Abstract
This paper describes and compares the infant care practices and beliefs of Maori, Tongan, Samoan, Cook Islands, Niuean and Pakeha (European) caregivers residing in Auckland, New Zealand. Focusing on four areas--sources of support and advice; infant feeding; infant sleeping arrangements; and traditional practices and beliefs--it explores inter-ethnic similarities and differences and intra-ethnic tensions. The international literature indicates that there can be significant cultural variation in infant care practices and in the meanings attributed to them. There is, however, little New Zealand literature on this topic, despite its importance for effective health service and health message delivery. Participants were primary caregivers of infants under 12 months. An average of six focus groups were conducted within each ethnic group, resulting in a total of 37 groups comprising 150 participants. We found similarities across all ethnic groups in the perceived importance of breastfeeding and the difficulties experienced in establishing and maintaining this practice. The spectrum of behaviours ranged widely with differences most pronounced between Pacific caregivers, especially those Island-raised, and Pakeha caregivers, especially those in nuclear families. Amongst the former, norms included: the family as central in providing support and advice; infant bedsharing; abdominal rubbing during pregnancy; baby massage; and the importance of adhering to traditional protocols to ensure infant well-being. Amongst the latter, norms included: strong reliance on professional advice; looser family support networks; the infant sleeping in a cot; and adherence to Western biomedical understandings of health and illness. Maori caregivers bridged the spectrum created by these groups and exhibited a diverse range of practices. Intra-cultural differences were present in all groups indicating the dynamic nature of cultural practices. They were most evident between Pacific-raised and New Zealand-raised Pacific caregivers, with the latter attempting to marry traditional with Western beliefs and practices.
- Published
- 2001
214. Does Equine Assisted Learning Create Emotionally Safe Learning Environments for At-Risk Youth?
- Author
-
Katie Cagle-Holtcamp, Molly Christine Nicodemus, Julie Parker, and Mattie Helen Dunlap
- Subjects
equine assisted learning ,emotional safety ,at-risk youth ,equine therapy ,Theory and practice of education ,LB5-3640 - Abstract
Equine assisted learning (EAL) is a form of experiential learning that is quickly growing in interest within the educational community. A challenge with experiential learning programs for at-risk youth is creating an emotionally safe environment that opens up the participants to learning. Nevertheless, EAL has been credited with the development of life skills in youth that promote educational achievement, but research tracking the development of emotional safety and learning, specifically associated with programming dedicated to educating participants about the horse, is limited. Therefore, the objective of this study was to determine if EAL, with programming centered around equine education, will promote emotional safety and learning in at-risk youth. Youth labeled as at-risk participated in a 4-week EAL session focused on teaching participants horse behavior, management, handling, and riding, while incorporating the 4 themes of emotional safety (self-esteem, personal security, respect, and connectivity). To determine participant learning of the equine topics covered, a pre- and post-program test was given to each participant. Acquirement of the themes of emotional safety was tracked for each participant using weekly debriefing interviews. While this was the first time to perform this assessment protocol for evaluating learning and emotional safety in at-risk youth, the completion rate for both forms of assessment utilized in this study was 100%. Evaluation of debriefing interview answers and test scores from the equine knowledge questions showed improvement by the end of the session in both equine knowledge and emotional safety, particularly as it relates to personal security. These results suggest EAL, with programming directed towards educating the participant about the horse, promotes emotional safety and learning for at-risk youth.
- Published
- 2019
- Full Text
- View/download PDF
215. Computed tomography in the evaluation of febrile neutropenic pediatric oncology patients
- Author
-
J. Russell Geyer, Julie Park, Douglas S. Hawkins, and Sarah Archibald
- Subjects
Microbiology (medical) ,Adult ,Male ,Radiography, Abdominal ,medicine.medical_specialty ,Neutropenia ,Adolescent ,Asymptomatic ,Fever of Unknown Origin ,Neoplasms ,Paranasal Sinuses ,medicine ,Humans ,Child ,Sinus (anatomy) ,Retrospective Studies ,Leukopenia ,business.industry ,Medical record ,Infant ,medicine.disease ,Infectious Diseases ,medicine.anatomical_structure ,El Niño ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Female ,Radiography, Thoracic ,Radiology ,medicine.symptom ,Abnormality ,business ,Tomography, X-Ray Computed ,Head ,Febrile neutropenia ,Neck - Abstract
Aim. To evaluate the diagnostic utility of computed tomography (CT) obtained during prolonged febrile neutropenia in pediatric oncology patients. Methods. We evaluated the medical records of all patients with a malignant disease who had a CT examination during an episode of febrile neutropenia lasting for 4 days or more at Children's Hospital and Regional Medical Center in Seattle, WA, between January 1, 1997, and June 1, 1999. Results. CT was performed on 83 patients to evaluate 109 episodes of prolonged febrile neutropenia. Sixty-eight (62%) of the initial CT scans demonstrated abnormalities, leading to changes in therapy in 42 (39%). The diagnostic and therapeutic utility of CT varied by anatomic site. Abdominal and head/neck CT detected abnormalities in only 19 and 8% of studies, respectively, resulting in therapy changes in 9 and 4%, respectively. Sinus CT demonstrated abnormalities in 41% of cases and altered therapy in 24%. Chest CT had the highest diagnostic utility, with 49% of cases demonstrating abnormalities, leading to therapy alteration in 30%. CT was rarely abnormal in the absence of localizing signs or symptoms. In 55 instances 1 or more follow-up scans were done. Thirteen follow-up CT scans showed abnormalities that led to a change in therapy. Conclusions. CT-detected abnormalities frequently lead to alterations in therapy, particularly sinus and thoracic CT. Most patients with CT-detected abnormalities have symptoms or signs referable to the site of abnormality. Asymptomatic febrile neutropenic children rarely have CT findings that lead to a change in therapy.
- Published
- 2001
216. An overview of the BioCreative 2012 Workshop Track III: interactive text mining task
- Author
-
Hans-Michael Müller, Wasila M. Dahdul, Kimberly Van Auken, Johnny Chi Yang Wu, Melissa A. Haendel, Robert J. Dodson, Donghui Li, Kevin G. Becker, Yuling Li, Chih-Hsuan Wei, Martin Krallinger, Jeyakumar Natarajan, Catalina O. Tudor, Mary L. Schaeffer, Suresh Subramani, Susan M. Bello, Petra Fey, W. John Wilbur, Marc Gillespie, Paula M. Mabee, Ceri E. Van Slyke, Hong Cui, S. Jimenez, Zhiyong Lu, Kalpana Raja, Phoebe M. Roberts, Ben Carterette, K. Bretonnel Cohen, Luana Licata, Laurel Cooper, Cathy H. Wu, Andrew Chatr-aryamontri, Juan Miguel Cejuela, Juancarlos Chan, James P. Balhoff, Bethany R. Harris, Cecilia N. Arighi, Lisa Matthews, Pratibha Dubey, Julie Park, and Harold J. Drabkin
- Subjects
Time Factors ,Computer science ,Documentation ,General Biochemistry, Genetics and Molecular Biology ,Education ,Task (project management) ,03 medical and health sciences ,Data Mining ,Humans ,Biocurator ,030304 developmental biology ,0303 health sciences ,Information retrieval ,Data curation ,Learnability ,End user ,business.industry ,030302 biochemistry & molecular biology ,Usability ,Data science ,Databases as Topic ,Original Article ,User interface ,General Agricultural and Biological Sciences ,business ,Software ,Information Systems - Abstract
In many databases, biocuration primarily involves literature curation, which usually involves retrieving relevant articles, extracting information that will translate into annotations and identifying new incoming literature. As the volume of biological literature increases, the use of text mining to assist in biocuration becomes increasingly relevant. A number of groups have developed tools for text mining from a computer science/linguistics perspective, and there are many initiatives to curate some aspect of biology from the literature. Some biocuration efforts already make use of a text mining tool, but there have not been many broad-based systematic efforts to study which aspects of a text mining tool contribute to its usefulness for a curation task. Here, we report on an effort to bring together text mining tool developers and database biocurators to test the utility and usability of tools. Six text mining systems presenting diverse biocuration tasks participated in a formal evaluation, and appropriate biocurators were recruited for testing. The performance results from this evaluation indicate that some of the systems were able to improve efficiency of curation by speeding up the curation task significantly (∼1.7- to 2.5-fold) over manual curation. In addition, some of the systems were able to improve annotation accuracy when compared with the performance on the manually curated set. In terms of inter-annotator agreement, the factors that contributed to significant differences for some of the systems included the expertise of the biocurator on the given curation task, the inherent difficulty of the curation and attention to annotation guidelines. After the task, annotators were asked to complete a survey to help identify strengths and weaknesses of the various systems. The analysis of this survey highlights how important task completion is to the biocurators’ overall experience of a system, regardless of the system’s high score on design, learnability and usability. In addition, strategies to refine the annotation guidelines and systems documentation, to adapt the tools to the needs and query types the end user might have and to evaluate performance in terms of efficiency, user interface, result export and traditional evaluation metrics have been analyzed during this task. This analysis will help to plan for a more intense study in BioCreative IV.
- Published
- 2013
217. Calling the Station Home: Place and Identity in New Zealandís High Country
- Author
-
Julie Park
- Subjects
Gerontology ,Index (economics) ,Anthropology ,Identity (social science) ,Sociology - Abstract
Calling the Station Home: Place and Identity in New Zealandis High Country. Michele D. Dominy. Lanham, MD: Rowman and Littlefield Publishers, 2001. xiii. 306 pp., figures, tables, maps, notes, bibliography, index.
- Published
- 2002
218. Abstract C135: Therapeutic targets for MYC-driven cancer
- Author
-
Maki Imakura, Masafumi Toyoshima, Ryan Walsh, Julie Park, Heather L. Howie, and Carla Grandori
- Subjects
Cancer Research ,Oncogene ,Wnt signaling pathway ,Druggability ,Cancer ,Biology ,medicine.disease ,Molecular biology ,Oncology ,CSNK1E ,Neuroblastoma ,medicine ,Cancer research ,Lethal allele ,Transcription factor - Abstract
Drugs directed toward oncoproteins have demonstrated efficacy while avoiding the systemic toxicity associated with standard chemotherapeutics. However, oncoproteins encoding for transcription factors, such as the MYC family, which are broadly implicated in many human cancers, are difficult to inhibit with small molecules or antibody based therapies. Thus, to target MYC-driven cancers, we have taken the approach of identifying druggable genes that exhibit a synthetic lethal relationship with aberrant MYC expression. Using an isogenic cell model system, we identified, via high throughput siRNA screening, more than 100 druggable genes that exhibit a synthetic lethal interaction with MYC (referred to as MYC-synthetic lethal genes, MYC-SL). Among the MYC-SL genes, we focused on casein kinase 1 epsilon (CSNK1e), whose relevance in MYC-driven human cancer was demonstrated by correlation between high levels of CSNK1e expression, MYCN amplification, and poor clinical prognosis in neuroblastoma cases. The requirement of CSNK1e for growth of neuroblastomas with MYCN amplification was validated in vivo by conditional knock-down and via a small molecule inhibitor of its activity. CSNK1e had previously been implicated in the regulation of WNT, however our data also suggest that in neuroblastoma the activity of CSNK1e is a key component of a positive autocrine circuit triggered by MYCN amplification that sustains both WNT and SHH pathways. In summary, our work elucidates a broad network of MYC synthetic lethal genes, perhaps a reflection of its widespread effects on gene expression, and demonstrates the power of high throughput siRNA screening as a rapid and unbiased approach to identify a network of synthetic lethal genes and potential new therapeutic targets functionally linked to a previously un-druggable oncogene. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2011 Nov 12-16; San Francisco, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2011;10(11 Suppl):Abstract nr C135.
- Published
- 2011
219. Using computational predictions to improve literature-based Gene Ontology annotations: a feasibility study
- Author
-
J. Michael Cherry, Maria C. Costanzo, Julie Park, Rama Balakrishnan, and Eurie L. Hong
- Subjects
InterPro ,Literature based ,Saccharomyces cerevisiae ,Biology ,Ontology (information science) ,Genome ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Annotation ,Databases, Genetic ,030304 developmental biology ,0303 health sciences ,Information retrieval ,Gene ontology ,030302 biochemistry & molecular biology ,Computational Biology ,Molecular Sequence Annotation ,Feasibility Studies ,Original Article ,Bibliographies as Topic ,Genome, Fungal ,General Agricultural and Biological Sciences ,Software ,Scope (computer science) ,Information Systems - Abstract
Annotation using Gene Ontology (GO) terms is one of the most important ways in which biological information about specific gene products can be expressed in a searchable, computable form that may be compared across genomes and organisms. Because literature-based GO annotations are often used to propagate functional predictions between related proteins, their accuracy is critically important. We present a strategy that employs a comparison of literature-based annotations with computational predictions to identify and prioritize genes whose annotations need review. Using this method, we show that comparison of manually assigned 'unknown' annotations in the Saccharomyces Genome Database (SGD) with InterPro-based predictions can identify annotations that need to be updated. A survey of literature-based annotations and computational predictions made by the Gene Ontology Annotation (GOA) project at the European Bioinformatics Institute (EBI) across several other databases shows that this comparison strategy could be used to maintain and improve the quality of GO annotations for other organisms besides yeast. The survey also shows that although GOA-assigned predictions are the most comprehensive source of functional information for many genomes, a large proportion of genes in a variety of different organisms entirely lack these predictions but do have manual annotations. This underscores the critical need for manually performed, literature-based curation to provide functional information about genes that are outside the scope of widely used computational methods. Thus, the combination of manual and computational methods is essential to provide the most accurate and complete functional annotation of a genome. Database URL: http://www.yeastgenome.org.
- Published
- 2011
220. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
- Author
-
Ankur Srivastava, Simcha Jong, Anna Gola, Ruth Gailer, Sarah Morgan, Karen Sennett, Sudeep Tanwar, Elena Pizzo, James O’Beirne, Emmanuel Tsochatzis, Julie Parkes, and William Rosenberg
- Subjects
Enhanced Liver fibrosis (ELF) ,Fibroscan ,NAFLD ,Cirrhosis detection ,Cost savings ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Abstract Background The identification of patients with advanced liver fibrosis secondary to non-alcoholic fatty liver disease (NAFLD) remains challenging. Using non-invasive liver fibrosis tests (NILT) in primary care may permit earlier detection of patients with clinically significant disease for specialist review, and reduce unnecessary referral of patients with mild disease. We constructed an analytical model to assess the clinical and cost differentials of such strategies. Methods A probabilistic decisional model simulated a cohort of 1000 NAFLD patients over 1 year from a healthcare payer perspective. Simulations compared standard care (SC) (scenario 1) to: Scenario 2: FIB-4 for all patients followed by Enhanced Liver Fibrosis (ELF) test for patients with indeterminate FIB-4 results; Scenario 3: FIB-4 followed by fibroscan for indeterminate FIB-4; Scenario 4: ELF alone; and Scenario 5: fibroscan alone. Model estimates were derived from the published literature. The primary outcome was cost per case of advanced fibrosis detected. Results Introduction of NILT increased detection of advanced fibrosis over 1 year by 114, 118, 129 and 137% compared to SC in scenarios 2, 3, 4 and 5 respectively with reduction in unnecessary referrals by 85, 78, 71 and 42% respectively. The cost per case of advanced fibrosis (METAVIR ≥F3) detected was £25,543, £8932, £9083, £9487 and £10,351 in scenarios 1, 2, 3, 4 and 5 respectively. Total budget spend was reduced by 25.2, 22.7, 15.1 and 4.0% in Scenarios 2, 3, 4 and 5 compared to £670 K at baseline. Conclusion Our analyses suggest that the use of NILT in primary care can increases early detection of advanced liver fibrosis and reduce unnecessary referral of patients with mild disease and is cost efficient. Adopting a two-tier approach improves resource utilization.
- Published
- 2019
- Full Text
- View/download PDF
221. Scoping review of mental health in prisons through the COVID-19 pandemic
- Author
-
Kerry Gutridge, Emma Plugge, Julie Parkes, Luke Johnson, and Anjana Roy
- Subjects
Medicine - Abstract
Objective To examine the extent, nature and quality of literature on the impact of the COVID-19 pandemic on the mental health of imprisoned people and prison staff.Design Scoping review.Data sources PubMed, Embase, CINAHL, Global Health, Cochrane, PsycINFO, PsychExtra, Web of Science and Scopus were searched for any paper from 2019 onwards that focused on the mental health impact of COVID-19 on imprisoned people and prison staff. A grey literature search focused on international and government sources and professional bodies representing healthcare, public health and prison staff was also performed. We also performed hand searching of the reference lists of included studies.Eligibility criteria for selection of studies All papers, regardless of study design, were included if they examined the mental health of imprisoned people or prison staff specifically during the COVID-19 pandemic. Imprisoned people could be of any age and from any countries. All languages were included. Two independent reviewers quality assessed appropriate papers.Results Of 647 articles found, 83 were eligible for inclusion, the majority (58%) of which were opinion pieces. The articles focused on the challenges to prisoner mental health. Fear of COVID-19, the impact of isolation, discontinuation of prison visits and reduced mental health services were all likely to have an adverse effect on the mental well-being of imprisoned people. The limited research and poor quality of articles included mean that the findings are not conclusive. However, they suggest a significant adverse impact on the mental health and well-being of those who live and work in prisons.Conclusions It is key to address the mental health impacts of the pandemic on people who live and work in prisons. These findings are discussed in terms of implications for getting the balance between infection control imperatives and the fundamental human rights of prison populations.
- Published
- 2021
- Full Text
- View/download PDF
222. Beyond stereotypes: a study of some New Zealand women alcohol drinkers
- Author
-
Julie Park
- Subjects
Consumption (economics) ,Stereotyping ,Alcohol Drinking ,Public Health, Environmental and Occupational Health ,Alcohol ,Context (language use) ,chemistry.chemical_compound ,Alcoholism ,Alcohol policy ,chemistry ,Risk Factors ,Social Conformity ,Environmental health ,Humans ,Female ,Psychology ,Alcohol consumption ,New Zealand - Abstract
A comparison of folk categories of types of drinker and recorded alcohol consumption data, both derived from New Zealand women, with established risky levels of drinking indicates that there is some correspondence between folk categories of non-‘ordinary’ drinking and drinking at epidemiologically defined risky levels. However, of more importance to the majority of women drinkers, women's drinking which is completely socially acceptable and certainly regarded as quite ‘ordinary’, can also be at or well above risky levels. These findings are discussed in the context of the increasing normalisation of alcohol in women's lives. I argue that they support a ‘reduced consumption’ rather than a ‘safe limits’ alcohol policy.
- Published
- 1991
223. 191. Identification of a Novel Functional Domain in the Sleeping Beauty Transposase: Towards Alleviating the Restriction of SB Overproduction Inhibition
- Author
-
Stephen R. Yant, Mark A. Kay, and Julie Park
- Subjects
Pharmacology ,Genetics ,Transposable element ,Mutant ,DNA-binding domain ,Biology ,Transposition (music) ,chemistry.chemical_compound ,chemistry ,Drug Discovery ,Molecular Medicine ,Overproduction ,Molecular Biology ,Transposase ,Function (biology) ,DNA - Abstract
DNA transposons such as Sleeping Beauty (SB) have been shown to be effective vectors for gene therapy. However, one limitation of the SB system is its regulation by a phenomenon known as overproduction inhibition (OPI), in which elevated concentrations of transposase enzyme inhibit the transposition reaction. In an attempt to characterize the mechanism behind this process, we studied the structure/function relationship of the wild-type SB10 protein|[mdash]|focusing on the region linking the N-terminal DNA binding domain and the C-terminal catalytic domain. This area of SB10 is not only highly conserved (55-60%) among the Tc1/Mariner family of transposases, but has also been previously implicated in adversely affecting SB's DNA binding ability. We first tested whether regions downstream of the transposase N-terminus contribute to SB10 DNA binding activity by analyzing various SB deletion mutants in a yeast one-hybrid assay for transposase-transposon interactions. Results show that the ability of the protein to bind transposon DNA increases exponentially in a manner that is proportional with the size of the C-terminal deletion. Mutational analyses of this inter-domain linker region indicate that it is important for transposase function since nearly all mutants analyzed were either completely inactive or 2-3 fold hyperactive in a quantitative transposition assay. To ascertain whether this newly-identified functional domain contributes to OPI, SB10 and five hyperactive mutants were assayed for transposition activity at increasing transposase:transposon ratios. All mutants demonstrated altered OPI titration curves as compared to SB10, with two distinct mutant classes emerging. Class 1 mutants yielded a curve which was shifted towards higher transposase:transposon ratios, but had the same maximum activity as the SB10 curve. In contrast, Class 2 mutants had transposition levels only reaching |[sim]|50% that of SB10. However, these curves were also shifted toward higher amounts of transposase. Based on the similar shift in curves for both types of mutants, we concluded that mutations in the linker domain resulted in an increased OPI threshold. To elucidate the molecular mechanism behind this change in SB regulation, we tested the binding abilities of these linker domain mutants using our yeast one-hybrid assay. We found that all the inactive transposase mutants were able to bind transposon DNA at least as well as SB10 and some of hyperactive mutants exhibited up to a 4-fold change in DNA binding ability. Though some of the mutants did show a dramatic change in transposon binding, we observed no obvious overall correlation between binding and transpositional regulation. However, based on an altered OPI curve of an N-terminal transposase mutant with known increased affinity for the transposon, we suspect that some relationship between binding and regulation exists. Although we do not as yet completely understand the mechanism behind OPI, our results indicate that it is possible to remove some of the stringency of SB self-inhibition. Through continued study of this regulatory process, we hope to eventually overcome this obstacle and improve the efficiency and utility of SB as a vehicle for gene transfer.
- Published
- 2005
224. 1084. A Screen for Host Cellular Proteins That Interact with Adeno-Associated Virus Capsid Proteins
- Author
-
Mark A. Kay, Daria Glazer, Bassel Akache, and Julie Park
- Subjects
Pharmacology ,Genetics ,cDNA library ,viruses ,Hypothetical protein ,Biology ,medicine.disease_cause ,SYT1 ,Virus ,Transduction (genetics) ,Capsid ,Drug Discovery ,medicine ,Molecular Medicine ,Molecular Biology ,Adeno-associated virus ,TAF15 - Abstract
Top of pageAbstract Vectors from adeno-associated virus (AAV) appear very promising for use in some gene therapy applications, and have even shown success in animal models. Different serotypes of AAV have been found, each having different properties. For example, it has been shown that AAV-8 uncoats more readily than AAV-2 in the nuclei of hepatocytes in mouse liver, possibly explaining the more robust AAV-8 |[ndash]|transduction efficiencies (Thomas et al., Journal of Virology, 2004, 78 (6) p. 3110|[ndash]|3224). Our goal is to better understand the mechanisms of AAV capsid uncoating in vivo. One approach is to identify cellular proteins that interact with the capsid, and perhaps establish if certain proteins interact with the capsids in a serotype-specific manner. Towards this end, we used a yeast two-hybrid screen to identify cellular proteins that interact with different domains of the AAV-8 capsid. In one of the screens, using the middle portion of the AAV capsid protein VP3 as bait against a mouse liver cDNA library, we found that over half of the library clones recovered encoded part of the same hypothetical ORF AK014478. These clones did interact with the corresponding portion of the AAV-2 capsid, indicating this interaction is not serotype-specific. However, they did not interact with the C- or N-terminal portions of the capsid protein. Homologues for this hypothetical protein have been found only in certain vertebrates and insects, and the human homologue has been shown to localize to the mitochondria. Additional clones isolated from these and related screens are currently being identified, and their association with AAV-capsid proteins are being verified by independent assays. By identifying these cellular proteins such as the one encoded by AK014478 we can better understand the mechanisms behind AAV entry and uncoating in the cell, and design better vectors for gene transfer.
- Published
- 2005
225. 819. Hyperactive Transposase Mutants of the Sleeping Beauty Transposon
- Author
-
Julie Park, Mark A. Kay, Jacob Giehm Mikkelsen, Stephen R. Yant, and Yong Huang
- Subjects
Pharmacology ,Transposable element ,Mutant ,Transfection ,Gene delivery ,Biology ,Sleeping Beauty transposon system ,Molecular biology ,Transposase activity ,Drug Discovery ,Genetics ,Recombinase ,Molecular Medicine ,Molecular Biology ,Transposase - Abstract
The Sleeping Beauty (SB) transposon system mediates stable genomic integration by a cut-and-paste transposition process and has shown tremendous success as a therapeutic vehicle for in vivo gene delivery. Nevertheless, the overall rate of transposition with SB is still insufficient for many clinical applications. Herein, we generated 141 missense mutants for the SB transposase and screened each for altered gene transfer activity in human cells using a genetic assay. We show that despite equivalent steady-state levels of wild-type (WT) and mutant transposases in transfected cells, many mutations introduced into the N-terminal DNA-binding domain (n=10) and C-terminal catalytic core domain (n=6) resulted in 2- to 4-fold higher transpositional efficiencies compared to WT. In order to better understand the transposition reaction for potential future development, we compared the functional activities of these hyperactive recombinases to that of the WT transposase using a combination of PCR and EMSAs. Results of these studies identified a number of pathways that contribute to improved transposase activity, including an altered affinity of the transposase for transposon ends, transposase conformational changes, enhanced donor cleavage activity, and increased rates of strand transfer. Importantly, many of these hyperactive SB (HSB) mutations functioned synergistically and, when combined with a hyperactive transposon, elevated transposition by 14-fold compared to the first-generation transposon system. Moreover, although WT and mutant transposases were negatively regulated at high enzyme concentrations, the HSB variants supported ~10-fold higher transpositional activity at all experimental doses, suggesting that lower doses could be administered to further improve the safety profile for SB in vivo. In addition, the use of HSB instead of the WT transposase dramatically improved the integration frequency of larger-sized elements, including ones greater than 14 kb in length. These HSB mutants should greatly extend the carrying capacity for SB, thus overcoming one of this system's major limitations. Finally, we studied the long-term in vivo persistence of two transposon reporters, β-galactosidase and human coagulation factor IX (hFIX), in the livers of adult mice following a single administration of WT- or hyperactive transposase-expressing plasmids. Results of these analyses demonstrated that these mutated enzymes could also greatly enhance SB's gene transfer capabilities in vivo, supporting stable integration in an estimated 57% of transfected mouse hepatocytes, compared to ~8% for the WT. This level of transposition was sufficient to maintain ~7-fold higher serum hFIX levels (955 ng/ml ± 241 ng/ml) than achieved in SB-expressing animals (140 ng/ml ± 56 ng/ml) for a period of 4 months (length of study). This level of hFIX obtained with the HSB mutant is ~19% of normal human levels and is well within a curative range capable of converting a severely affected hemophilia B patient to one with a much milder phenotype. Therefore, our work demonstrates the potential for improved in vivo gene delivery through directed transposase evolution, and provides a number of important insights into Sleeping Beauty transposon biology that could be exploited for future development.
- Published
- 2004
226. 148. The Altered Binding Properties of Sleeping Beauty Transposase Hyperactive Mutants May Explain Their Enhanced Efficacy
- Author
-
Mark A. Kay, Stephen R. Yant, and Julie Park
- Subjects
Pharmacology ,Transposable element ,Genetics ,Oligonucleotide ,Inverted repeat ,Mutant ,Biology ,chemistry.chemical_compound ,chemistry ,Drug Discovery ,Molecular Medicine ,Electrophoretic mobility shift assay ,Binding site ,Molecular Biology ,Transposase ,DNA - Abstract
Top of pageAbstract The Sleeping Beauty (SB) transposon system has been shown as an effective vector to mediate stable, long-term gene transfer. We have previously identified SB hyperactive mutants through an alanine scan of the DNA binding region of the transposase. In total, 96 single-substitution mutants were generated and those individual missense mutations leading to increased activity were combined to generate four hyperactive Sleeping Beauty (HSB) mutants. In this study, we have begun to delve into the mechanism behind the increased activity of these mutants by comparing the four HSB mutants and wild-type transposase for their ability to bind the DNA-recognition sites. Truncated (N123) derivatives of wild-type and hyperactive SB proteins were generated by in vitro transcription/translation and tested for their ability to bind to oligos corresponding to transposase binding sites in an electrophoretic mobility shift assay. Each SB transposon inverted repeat contains two transposase binding sites, an outer binding site (OBS) adjacent to the transposon boundary and an inner binding site (IBS) internally situated about 165bp from the OBS. We found that there was no change in the binding affinities of the hyperactive mutants versus wild-type for the IBS but that binding to the OBS was increased 2–4 fold. Our results in conjunction with previous work, where it was shown that simply increasing the binding affinity of the transposase at the transposon terminal end causes the abolishment of transposition (Cui et al, J Mol Biol, 1221–1235; 2002), suggest that the mechanisms underlying hyperactivity may be due to an enhanced ability of these mutants to form an active synaptic complex and we are in the process of investigating this possibility. We are also examining all of the single-substitution mutants to determine which individual residues contribute to increased binding affinity. Through these experiments we hope to gain additional insight into the mechanisms involved in transposase function which, in turn, will lead to further enhancement of SB as a tool for gene transfer.
- Published
- 2004
227. BALUJA ET AL. RESPOND
- Author
-
Kaari F. Baluja, Dowell Myers, and Julie Park
- Subjects
Current Population Survey ,media_common.quotation_subject ,Immigration ,Public Health, Environmental and Occupational Health ,Paan ,Regret ,Criminology ,Convention ,Cigarette smoking ,Law ,Cultural diversity ,Sociology ,Meaning (existential) ,media_common - Abstract
McCarthy and his colleagues raise interesting questions about smoking behavior in other countries. Our research, however, is restricted to the smoking behavior of foreign-born men and women in the United States. We apologize for any confusion about the meaning of “country of origin.” We follow the convention of most immigration research by using country of birth. That should resolve the doubts expressed by the letter writers regarding the treatment of migrants who stop over in, for example, Canada before settling in the United States. We regret that the tobacco use supplement data from the Current Population Survey prevent us from exploring the use of alternative tobacco products such as bidis or paan. The data in question pertain primarily to cigarette smoking. There may well be cultural differences in what is considered “smoking.” This is always a challenge when making cross-cultural comparisons.
- Published
- 2003
228. Respectable Lives: Social Standing in Rural New Zealand . ELVIN HATCH
- Author
-
Julie Park
- Subjects
Anthropology ,Gender studies ,Sociology ,Social status - Published
- 1994
229. ELEVATED INTRACRANIAL PRESSURE IN A PATIENT WITH UNILATERAL DISC EDEMA
- Author
-
Barry Schanzer, Christopher Quinn, and Julie Park
- Subjects
Ophthalmology ,business.industry ,Anesthesia ,Edema ,Medicine ,Elevated Intracranial Pressure ,medicine.symptom ,business ,Optometry - Published
- 2002
230. Misclassification of coffee consumption data and the development of a standardised coffee unit measure
- Author
-
Paul Roderick, Sean Ewings, Robin Poole, Julie Parkes, and Jonathan A Fallowfield
- Subjects
Nutritional diseases. Deficiency diseases ,RC620-627 - Abstract
Background Associations of coffee consumption with multiple health outcomes have been researched extensively. Coffee consumption, usually reported in cups a day, is a heterogeneous measure due to numerous preparation methods and cup sizes, leading to misclassification. This paper develops a new ‘unit’ measure of coffee and uses coffee consumption data from a representative sample of the UK population to assess misclassification when cup volume and preparation type are not taken into account.Methods A coffee unit measure was created using published estimates of caffeine and chlorogenic acid concentrations, and applied across volumes and preparation types. Four-day food diary data in adults from the UK National Diet and Nutrition Survey (NDNS; 2012–2016) were used to quantify coffee intake. Participant self-reported cups a day were compared with cups a day standardised by (a) 227 mL volume and (b) 227 mL instant coffee equivalents (unit measure), and the degree of misclassification was derived. Sensitivity analyses were conducted to model coffee drinking preferences of different populations and caffeine:chlorogenic acid weighting assumptions of the unit measure.Results The NDNS sample consisted of 2832 adult participants. Coffee was consumed by 62% of participants. Types varied, with 75% of caffeinated coffee cups being instant, 17% filter, 3% latte, 2% cappuccino, 2% espresso and
- Published
- 2020
- Full Text
- View/download PDF
231. Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease
- Author
-
Paul Roderick, Julie Parkes, Theresa Hydes, Ryan Buchanan, Oliver J Kennedy, and Simon Fraser
- Subjects
Medicine - Abstract
Objectives To investigate if non-alcoholic fatty liver disease (NAFLD) impacts mortality and adverse outcomes for individuals with chronic kidney disease (CKD).Design Systematic review.Data sources PubMed, EMBASE and Web of Science were searched up to 1 February 2020 with no restriction on the earliest date.Eligibility criteria for selecting studies Observational cohort studies that reported either the risk of all-cause mortality, incidence of non-fatal cardiovascular events (CVE) or progression of kidney disease among adults with established CKD who have NAFLD compared with those without.Data extraction and synthesis Two reviewers extracted data and assessed bias independently.Results Of 2604 records identified, 3 studies were included (UK (n=852), South Korea (n=1525) and USA (n=1413)). All were judged to have a low or moderate risk of bias. Data were insufficient for meta-analysis. Two studies examined the influence of NAFLD on all-cause mortality. One reported a significant positive association for NAFLD with all-cause mortality for individuals with CKD (p
- Published
- 2020
- Full Text
- View/download PDF
232. EDITORIAL.
- Author
-
Julie Park
- Subjects
ANTHROPOLOGY ,ETHNOMUSICOLOGY - Abstract
An introduction is presented in which the editor discusses various reports within the issue on papers from various disciplines including anthropology, cultural studies, and ethnomusicology.
- Published
- 2016
- Full Text
- View/download PDF
233. Comprehensive Profiling of the Cell Surface Proteome of Sy5Y Neuroblastoma Cells Yields a Subset of Proteins Associated with Tumor Differentiation.
- Author
-
Jacob Garcia, Vitor Faca, Jason Jarzembowski, Qing Zhang, Julie Park, and Samir Hanash
- Published
- 2009
- Full Text
- View/download PDF
234. The Anterolateral Thigh Flap is Highly Effective for Reconstruction of Complex Lower Extremity Trauma.
- Author
-
Julie Park
- Published
- 2007
- Full Text
- View/download PDF
235. Hepatitis C bio-behavioural surveys in people who inject drugs—a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling
- Author
-
Ryan Buchanan, Salim I. Khakoo, Jonathan Coad, Leonie Grellier, and Julie Parkes
- Subjects
Hepatitis C ,Prevalence ,Respondent-driven sampling ,Intravenous ,Drug ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background New, more effective and better-tolerated therapies for hepatitis C (HCV) have made the elimination of HCV a feasible objective. However, for this to be achieved, it is necessary to have a detailed understanding of HCV epidemiology in people who inject drugs (PWID). Respondent-driven sampling (RDS) can provide prevalence estimates in hidden populations such as PWID. The aims of this systematic review are to identify published studies that use RDS in PWID to measure the prevalence of HCV, and compare each study against the STROBE-RDS checklist to assess their sensitivity to the theoretical assumptions underlying RDS. Method Searches were undertaken in accordance with PRISMA systematic review guidelines. Included studies were English language publications in peer-reviewed journals, which reported the use of RDS to recruit PWID to an HCV bio-behavioural survey. Data was extracted under three headings: (1) survey overview, (2) survey outcomes, and (3) reporting against selected STROBE-RDS criteria. Results Thirty-one studies met the inclusion criteria. They varied in scale (range 1–15 survey sites) and the sample sizes achieved (range 81–1000 per survey site) but were consistent in describing the use of standard RDS methods including: seeds, coupons and recruitment incentives. Twenty-seven studies (87%) either calculated or reported the intention to calculate population prevalence estimates for HCV and two used RDS data to calculate the total population size of PWID. Detailed operational and analytical procedures and reporting against selected criteria from the STROBE-RDS checklist varied between studies. There were widespread indications that sampling did not meet the assumptions underlying RDS, which led to two studies being unable to report an estimated HCV population prevalence in at least one survey location. Conclusion RDS can be used to estimate a population prevalence of HCV in PWID and estimate the PWID population size. Accordingly, as a single instrument, it is a useful tool for guiding HCV elimination. However, future studies should report the operational conduct of each survey in accordance with the STROBE-RDS checklist to indicate sensitivity to the theoretical assumptions underlying the method. Systematic review registration PROSPERO CRD42015019245
- Published
- 2017
- Full Text
- View/download PDF
236. Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- Author
-
Paul M Trembling, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Julie Parkes, Andy Ryan, Sudeep Tanwar, Matthew Burnell, Ian Jacobs, Usha Menon, and William M. Rosenberg
- Subjects
Chronic liver disease ,Cirrhosis ,Alcohol ,Body mass index ,Obesity ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background We investigated the risk of chronic liver disease (CLD) due to alcohol consumption and body mass index (BMI) and the effects of their interaction in a prospective cohort study of women recruited to the UKCTOCS trial. Methods 95,126 post-menopausal women without documented CLD were stratified into 12 groups defined by combinations of BMI (normal, overweight, obese) and alcohol consumption (none,
- Published
- 2017
- Full Text
- View/download PDF
237. Erratum to: Methods for evaluating medical tests and biomarkers
- Author
-
Gowri Gopalakrishna, Miranda Langendam, Rob Scholten, Patrick Bossuyt, Mariska Leeflang, Anna Noel-Storr, James Thomas, Iain Marshall, Byron Wallace, Penny Whiting, Clare Davenport, Gowri GopalaKrishna, Isabel de Salis, Sue Mallett, Robert Wolff, Richard Riley, Marie Westwood, Jos Kleinen, Gary Collins, Hans Reitsma, Karel Moons, Antonia Zapf, Annika Hoyer, Katharina Kramer, Oliver Kuss, J. Ensor, J. J. Deeks, E. C. Martin, R. D. Riley, Gerta Rücker, Susanne Steinhauser, Martin Schumacher, Joie Ensor, Kym Snell, Brian Willis, Thomas Debray, Jon Deeks, Lavinia Ferrante di Ruffano, Sian Taylor-Phillips, Chris Hyde, Stuart A. Taylor, Gauraang Batnagar, STREAMLINE COLON Investigators, STREAMLINE LUNG Investigators, METRIC Investigators, Lavinia Ferrante Di Ruffano, Farah Seedat, Aileen Clarke, Sarah Byron, Frances Nixon, Rebecca Albrow, Thomas Walker, Carla Deakin, Zhivko Zhelev, Harriet Hunt, Yaling Yang, Lucy Abel, James Buchanan, Thomas Fanshawe, Bethany Shinkins, Laure Wynants, Jan Verbakel, Sabine Van Huffel, Dirk Timmerman, Ben Van Calster, Aeliko Zwinderman, Jason Oke, Jack O’Sullivan, Rafael Perera, Brian Nicholson, Hannah L. Bromley, Tracy E. Roberts, Adele Francis, Denniis Petrie, G. Bruce Mann, Kinga Malottki, Holly Smith, Lucinda Billingham, Alice Sitch, Oke Gerke, Mie Holm-Vilstrup, Eivind Antonsen Segtnan, Ulrich Halekoh, Poul Flemming Høilund-Carlsen, Bernard G. Francq, Jac Dinnes, Julie Parkes, Walter Gregory, Jenny Hewison, Doug Altman, William Rosenberg, Peter Selby, Julien Asselineau, Paul Perez, Aïssatou Paye, Emilie Bessede, Cécile Proust-Lima, Christiana Naaktgeboren, Joris de Groot, Anne Rutjes, Johannes Reitsma, Emmanuel Ogundimu, Jonathan Cook, Yannick Le Manach, Yvonne Vergouwe, Romin Pajouheshnia, Rolf Groenwold, Karen Moons, Linda Peelen, Daan Nieboer, Bavo De Cock, Micael J. Pencina, Ewout W. Steyerberg, Jennifer Cooper, Nick Parsons, Chris Stinton, Steve Smith, Andy Dickens, Rachel Jordan, Alexandra Enocson, David Fitzmaurice, Peymane Adab, Charles Boachie, Gaj Vidmar, Karoline Freeman, Martin Connock, Rachel Court, Carl Moons, Jessica Harris, Andrew Mumford, Zoe Plummer, Kurtis Lee, Barnaby Reeves, Chris Rogers, Veerle Verheyden, Gianni D. Angelini, Gavin J. Murphy, Jeremy Huddy, Melody Ni, Katherine Good, Graham Cooke, George Hanna, Jie Ma, K. G. M. (Carl) Moons, Joris A. H. de Groot, Doug G. Altman, Johannes B. Reitsma, Gary S. Collins, Karel G. M. Moons, Douglas G. Altman, Adina Najwa Kamarudin, Ruwanthi Kolamunnage-Dona, Trevor Cox, Simone Borsci, Teresa Pérez, M.Carmen Pardo, Angel Candela-Toha, Alfonso Muriel, Javier Zamora, Sabina Sanghera, Syed Mohiuddin, Richard Martin, Jenny Donovan, Joanna Coast, Mikyung Kelly Seo, John Cairns, Elizabeth Mitchell, Alison Smith, Judy Wright, Peter Hall, Michael Messenger, Nicola Calder, Nyantara Wickramasekera, Karen Vinall-Collier, Andrew Lewington, Johanna Damen, David Cairns, Michelle Hutchinson, Cathie Sturgeon, Liz Mitchel, Rebecca Kift, Sofia Christakoudi, Manohursingh Rungall, Paula Mobillo, Rosa Montero, Tjir-Li Tsui, Sui Phin Kon, Beatriz Tucker, Steven Sacks, Chris Farmer, Terry Strom, Paramit Chowdhury, Irene Rebollo-Mesa, Maria Hernandez-Fuentes, Johanna A. A. G. Damen, Thomas P. A. Debray, Pauline Heus, Lotty Hooft, Rob J. P. M. Scholten, Ewoud Schuit, Ioanna Tzoulaki, Camille M. Lassale, George C. M. Siontis, Virginia Chiocchia, Corran Roberts, Michael Maia Schlüssel, Stephen Gerry, James A. Black, Yvonne T. van der Schouw, Linda M. Peelen, Graeme Spence, David McCartney, Ann van den Bruel, Daniel Lasserson, Gail Hayward, Werner Vach, Antoinette de Jong, Coreline Burggraaff, Otto Hoekstra, Josée Zijlstra, Henrica de Vet, Sara Graziadio, Joy Allen, Louise Johnston, Rachel O’Leary, Michael Power, Louise Johnson, Ray Waters, John Simpson, Thomas R. Fanshawe, Peter Phillips, Andrew Plumb, Emma Helbren, Steve Halligan, Alastair Gale, Peggy Sekula, Willi Sauerbrei, Julia R. Forman, Susan J. Dutton, Yemisi Takwoingi, Elizabeth M. Hensor, Thomas E. Nichols, Emmanuelle Kempf, Raphael Porcher, Jennifer de Beyer, Douglas Altman, Sally Hopewell, John Dennis, Beverley Shields, Angus Jones, William Henley, Ewan Pearson, Andrew Hattersley, on behalf of the MASTERMIND consortium, Fueloep Scheibler, Anne Rummer, Sibylle Sturtz, Robert Großelfinger, Katie Banister, Craig Ramsay, Augusto Azuara-Blanco, Jennifer Burr, Manjula Kumarasamy, Rupert Bourne, Ijeoma Uchegbu, Jennifer Murphy, Alex Carter, Jen Murphy, Joachim Marti, Julie Eatock, Julie Robotham, Maria Dudareva, Mark Gilchrist, Alison Holmes, Phillip Monaghan, Sarah Lord, Andrew StJohn, Sverre Sandberg, Christa Cobbaert, Lieselotte Lennartz, Wilma Verhagen-Kamerbeek, Christoph Ebert, Andrea Horvath, for the Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine, Kevin Jenniskens, Jaime Peters, Bogdan Grigore, Obi Ukoumunne, Brooke Levis, Andrea Benedetti, Alexander W. Levis, John P. A. Ioannidis, Ian Shrier, Pim Cuijpers, Simon Gilbody, Lorie A. Kloda, Dean McMillan, Scott B Patten, Russell J. Steele, Roy C Ziegelstein, Charles H. Bombardier, Flavia de Lima Osório, Jesse R. Fann, Dwenda Gjerdingen, Femke Lamers, Manote Lotrakul, Sonia R Loureiro, Bernd Löwe, Juwita Shaaban, Lesley Stafford, Henk C. P. M. van Weert, Mary A. Whooley, Linda S. Williams, Karin A. Wittkampf, Albert S. Yeung, Brett D. Thombs, Chris Cooper, Tom Nieto, Claire Smith, Olga Tucker, Janine Dretzke, Andrew Beggs, Nirmala Rai, Sue Bayliss, Simon Stevens, Sue Mallet, Sudha Sundar, Emma Hall, Nuria Porta, David Lorente Estelles, Johann de Bono, and on behalf of the CTC-STOP protocol development group
- Subjects
Medicine (General) ,R5-920 - Published
- 2017
- Full Text
- View/download PDF
238. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21).
- Author
-
Alain Charest, Keara Lane, Kevin McMahon, Julie Park, Elizabeth Preisinger, Helen Conroy, and David Housman
- Published
- 2003
- Full Text
- View/download PDF
239. Baseline characteristics and outcomes of the main perpetrator programme within the Hampshire Domestic Abuse Prevention Partnership, UK: A mixed methods study.
- Author
-
Sara Afshar Morgan, Beth Mary Stevens McCausland, and Julie Parkes
- Subjects
Medicine ,Science - Abstract
Effective perpetrator programmes should be embedded within a community response, engage all types of perpetrators and involve an educational approach that integrates the survivor's voice. The Domestic Abuse Prevention Partnership (DAPP) is a transformative partnership based in the UK that aims to provide an integrated approach for perpetrators and survivors. This pragmatic mixed methods study was conducted to examine the baseline characteristics and individual outcomes of the main perpetrator programme within the DAPP. Applying a triangulation design, routine police re-offending aggregated data, pre- and post- perpetrator programme questionnaires, in-depth interviews with survivors, and focus-group discussions with perpetrators (clients) were integrated. Statistical analysis and thematic analysis were applied to quantitative and qualitative data, respectively. The majority of clients (47%) referred through the DAPP (n = 228) described wanting to make their relationship better as the main reason for engaging with the main perpetrators programme. Post-perpetrator programme questionnaires identified positive changes in both emotional behaviours and physical behaviours amongst clients, which were also supported by examples of improved relationships with their children described in survivor interviews. Three themes were described: first, making positive progress; second, impact of the children's module; and concerns around sustaining new behaviours. Over the monitoring period, 1 in 5 clients were either suspected or convicted of domestic abuse crimes following the programme. This suggests that further maintenance of positive behaviours and reinforcements are required for some clients. Given that clients felt children were a strong motivating factor for completing a programme, it seemed paradoxical that no specialist services were made available for them. Future reiterations of the DAPP model should at least address how best to work with children in families where domestic abuse occurs.
- Published
- 2019
- Full Text
- View/download PDF
240. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
- Author
-
Peter J Selby, Rosamonde E Banks, Walter Gregory, Jenny Hewison, William Rosenberg, Douglas G Altman, Jonathan J Deeks, Christopher McCabe, Julie Parkes, Catharine Sturgeon, Douglas Thompson, Maureen Twiddy, Janine Bestall, Joan Bedlington, Tilly Hale, Jacqueline Dinnes, Marc Jones, Andrew Lewington, Michael P Messenger, Vicky Napp, Alice Sitch, Sudeep Tanwar, Naveen S Vasudev, Paul Baxter, Sue Bell, David A Cairns, Nicola Calder, Neil Corrigan, Francesco Del Galdo, Peter Heudtlass, Nick Hornigold, Claire Hulme, Michelle Hutchinson, Carys Lippiatt, Tobias Livingstone, Roberta Longo, Matthew Potton, Stephanie Roberts, Sheryl Sim, Sebastian Trainor, Matthew Welberry Smith, James Neuberger, Douglas Thorburn, Paul Richardson, John Christie, Neil Sheerin, William McKane, Paul Gibbs, Anusha Edwards, Naeem Soomro, Adebanji Adeyoju, Grant D Stewart, and David Hrouda
- Subjects
biomarkers ,liver disease ,kidney disease ,prostate-specific antigen ,monitoring trials ,simulation of biomarker studies ,elf test ,elucidate ,renal cancer ,renal transplantation ,diagnosis of cirrhosis ,Public aspects of medicine ,RA1-1270 - Abstract
Background: Protein biomarkers with associations with the activity and outcomes of diseases are being identified by modern proteomic technologies. They may be simple, accessible, cheap and safe tests that can inform diagnosis, prognosis, treatment selection, monitoring of disease activity and therapy and may substitute for complex, invasive and expensive tests. However, their potential is not yet being realised. Design and methods: The study consisted of three workstreams to create a framework for research: workstream 1, methodology – to define current practice and explore methodology innovations for biomarkers for monitoring disease; workstream 2, clinical translation – to create a framework of research practice, high-quality samples and related clinical data to evaluate the validity and clinical utility of protein biomarkers; and workstream 3, the ELF to Uncover Cirrhosis as an Indication for Diagnosis and Action for Treatable Event (ELUCIDATE) randomised controlled trial (RCT) – an exemplar RCT of an established test, the ADVIA Centaur® Enhanced Liver Fibrosis (ELF) test (Siemens Healthcare Diagnostics Ltd, Camberley, UK) [consisting of a panel of three markers – (1) serum hyaluronic acid, (2) amino-terminal propeptide of type III procollagen and (3) tissue inhibitor of metalloproteinase 1], for liver cirrhosis to determine its impact on diagnostic timing and the management of cirrhosis and the process of care and improving outcomes. Results: The methodology workstream evaluated the quality of recommendations for using prostate-specific antigen to monitor patients, systematically reviewed RCTs of monitoring strategies and reviewed the monitoring biomarker literature and how monitoring can have an impact on outcomes. Simulation studies were conducted to evaluate monitoring and improve the merits of health care. The monitoring biomarker literature is modest and robust conclusions are infrequent. We recommend improvements in research practice. Patients strongly endorsed the need for robust and conclusive research in this area. The clinical translation workstream focused on analytical and clinical validity. Cohorts were established for renal cell carcinoma (RCC) and renal transplantation (RT), with samples and patient data from multiple centres, as a rapid-access resource to evaluate the validity of biomarkers. Candidate biomarkers for RCC and RT were identified from the literature and their quality was evaluated and selected biomarkers were prioritised. The duration of follow-up was a limitation but biomarkers were identified that may be taken forward for clinical utility. In the third workstream, the ELUCIDATE trial registered 1303 patients and randomised 878 patients out of a target of 1000. The trial started late and recruited slowly initially but ultimately recruited with good statistical power to answer the key questions. ELF monitoring altered the patient process of care and may show benefits from the early introduction of interventions with further follow-up. The ELUCIDATE trial was an ‘exemplar’ trial that has demonstrated the challenges of evaluating biomarker strategies in ‘end-to-end’ RCTs and will inform future study designs. Conclusions: The limitations in the programme were principally that, during the collection and curation of the cohorts of patients with RCC and RT, the pace of discovery of new biomarkers in commercial and non-commercial research was slower than anticipated and so conclusive evaluations using the cohorts are few; however, access to the cohorts will be sustained for future new biomarkers. The ELUCIDATE trial was slow to start and recruit to, with a late surge of recruitment, and so final conclusions about the impact of the ELF test on long-term outcomes await further follow-up. The findings from the three workstreams were used to synthesise a strategy and framework for future biomarker evaluations incorporating innovations in study design, health economics and health informatics. Trial registration: Current Controlled Trials ISRCTN74815110, UKCRN ID 9954 and UKCRN ID 11930. Funding: This project was funded by the NIHR Programme Grants for Applied Research programme and will be published in full in Programme Grants for Applied Research; Vol. 6, No. 3. See the NIHR Journals Library website for further project information.
- Published
- 2018
- Full Text
- View/download PDF
241. S. AureusCas9 Leads to Higher Sickle Mutation Correction Compared to S. PyogenesCas9 in Patient Hematopoietic Stem and Progenitor Cells
- Author
-
Yoo, Byoungyong, Park, So Hyun Julie Park, Zhang, Yankai, Sheehan, Vivien A., and Bao, Gang
- Abstract
Introduction: Sickle cell disease (SCD) is a red blood cell disorder caused by a single nucleotide mutation in the β-globin gene (HBB). Allogeneic hematopoietic stem cell transplantation (HSCT) is the only available cure, but is available to only a minority of patients and can be associated with high morbidity and mortality. CRISPR/Cas9 mediated genome editing may provide a permanent cure for SCD patients by correcting the sickle mutation in HBBin hematopoietic stem and progenitor cells (HSPCs). Previously, we achieved ~39% sickle mutation correction in SCD HSPCs by delivering S. pyogenes(Spy) Cas9/R-66S gRNA as ribonucleoprotein (RNP) and single-stranded oligodeoxynucleotides (ssODN) corrective donor template. S. aureus(Sau) Cas9 has potentially advantageous properties to improve therapeutic gene editing efficiency and safety, including smaller size allowing for efficient in vivodelivery and longer Protospacer Adjacent Motif (PAM) sequence for higher specificity. However, although in general, the cutting efficiency of SauCas9 is lower than SpyCas9, the differences in gene correction and other gene-editing outcomes between SpyCas9 and SauCas9 have not been well studied.
- Published
- 2021
- Full Text
- View/download PDF
242. Coffee, caffeine and non-alcoholic fatty liver disease?
- Author
-
Oliver John Kennedy, Paul Roderick, Robin Poole, and Julie Parkes
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Published
- 2016
- Full Text
- View/download PDF
243. Genome Snapshot: a new resource at the Saccharomyces Genome Database (SGD) presenting an overview of the Saccharomyces cerevisiae genome
- Author
-
Stuart R. Miyasato, David Botstein, Anand Sethuraman, Mayank K. Thanawala, Shuai Weng, Chandra L. Theesfeld, Kara Dolinski, J. Michael Cherry, Dianna G. Fisk, Mark Schroeder, Qing Dong, Rose Oughtred, Michael S. Livstone, Julie Park, Karen R. Christie, Eurie L. Hong, Marek S. Skrzypek, Selina S. Dwight, Stacia R. Engel, Rama Balakrishnan, Rey Andrada, Maria C. Costanzo, Gail Binkley, Jennifer M. Williams, Barry Starr, Christopher Lane, Jodi E. Hirschman, and Robert S. Nash
- Subjects
Saccharomyces cerevisiae Proteins ,Genomics ,Saccharomyces cerevisiae ,ENCODE ,Genome ,Saccharomyces ,Article ,03 medical and health sciences ,Annotation ,User-Computer Interface ,0302 clinical medicine ,Databases, Genetic ,Genetics ,Computer Graphics ,natural sciences ,030304 developmental biology ,0303 health sciences ,Internet ,biology ,Genome project ,biology.organism_classification ,ComputingMethodologies_PATTERNRECOGNITION ,Snapshot (computer storage) ,ComputingMethodologies_GENERAL ,Chromosomes, Fungal ,Genome, Fungal ,030217 neurology & neurosurgery ,Reference genome - Abstract
Sequencing and annotation of the entire Saccharomyces cerevisiae genome has made it pos- sible to gain a genome-wide perspective on yeast genes and gene products. To make this information available on an ongoing basis, the Saccharomyces 20Genome Database (SGD) (http://www.yeastgenome. org/) has created the Genome Snapshot (http://db. yeastgenome.org/cgi-bin/genomeSnapShot.pl). The Genome Snapshot summarizes the current state of knowledge about the genes and chromosomal fea- 25tures of S.cerevisiae. The information is organized into two categories: (i) number of each type of chro- mosomal feature annotated in the genome and (ii) number and distribution of genes annotated to Gene Ontology terms. Detailed lists are accessible 30through SGD's Advanced Search tool (http://db. yeastgenome.org/cgi-bin/search/featureSearch), and all the data presented on this page are available from the SGD ftp site (ftp://ftp.yeastgenome.org/ yeast/).
244. REVIEW
- Author
-
Julie Park
- Subjects
History and Philosophy of Science ,Anthropology - Published
- 1975
245. Catalyst Initiation in the Oscillatory Carbonylation Reaction
- Author
-
Katarina Novakovic and Julie Parker
- Subjects
Chemical engineering ,TP155-156 - Abstract
Palladium(II) iodide is used as a catalyst in the phenylacetylene oxidative carbonylation reaction that has demonstrated oscillatory behaviour in both pH and heat of reaction. In an attempt to extract the reaction network responsible for the oscillatory nature of this reaction, the system was divided into smaller parts and they were studied. This paper focuses on understanding the reaction network responsible for the initial reactions of palladium(II) iodide within this oscillatory reaction. The species researched include methanol, palladium(II) iodide, potassium iodide, and carbon monoxide. Several chemical reactions were considered and applied in a modelling study. The study revealed the significant role played by traces of water contained in the standard HPLC grade methanol used.
- Published
- 2011
- Full Text
- View/download PDF
246. Combining guilt-by-association and guilt-by-profiling to predict Saccharomyces cerevisiae gene function
- Author
-
Francis D. Gibbons, Frederick P. Roth, Weidong Tian, J. Michael Cherry, Julie Park, Zeba Wunderlich, Lan V. Zhang, Oliver D. King, and Murat Tasan
- Subjects
Saccharomyces cerevisiae Proteins ,Bioinformatics ,Genes, Fungal ,Saccharomyces cerevisiae ,Method ,Computational biology ,Correlation ,03 medical and health sciences ,0302 clinical medicine ,Information and Computing Sciences ,Profiling (information science) ,Gene ,030304 developmental biology ,Genetics ,0303 health sciences ,biology ,Computational genomics ,Computational Biology ,Biological Sciences ,Guilt by association ,biology.organism_classification ,Functional linkage ,Human genetics ,Fungal ,Genes ,Environmental Sciences ,Algorithms ,Metabolic Networks and Pathways ,Software ,030217 neurology & neurosurgery - Abstract
Background: Learning the function of genes is a major goal of computational genomics. Methods for inferring gene function have typically fallen into two categories: 'guilt-by-profiling', which exploits correlation between function and other gene characteristics; and 'guilt-by-association', which transfers function from one gene to another via biological relationships. Results: We have developed a strategy ('Funckenstein') that performs guilt-by-profiling and guilt-by-association and combines the results. Using a benchmark set of functional categories and input data for protein-coding genes in Saccharomyces cerevisiae, Funckenstein was compared with a previous combined strategy. Subsequently, we applied Funckenstein to 2,455 Gene Ontology terms. In the process, we developed 2,455 guilt-by-profiling classifiers based on 8,848 gene characteristics and 12 functional linkage graphs based on 23 biological relationships. Conclusion: Funckenstein outperforms a previous combined strategy using a common benchmark dataset. The combination of 'guilt-by-profiling' and 'guilt-by-association' gave significant improvement over the component classifiers, showing the greatest synergy for the most specific functions. Performance was evaluated by cross-validation and by literature examination of the top-scoring novel predictions. These quantitative predictions should help prioritize experimental study of yeast gene functions.
- Full Text
- View/download PDF
247. A Consideration Of The Tikopia 'sacred Tale', By Julie Park, P 154-175 (Journal of the Polynesian Society)
- Author
-
Julie Park
248. Can Habitus Help, By Julie Park And Carolyn Morris, P 227-262 (Journal of the Polynesian Society: Reproducing Samoans In Auckland 'In Different Times')
- Author
-
Julie Park and Carolyn Morris
249. Why Is Wine Not Booze? By Julie Park, P 147-151 (Journal of the Polynesian Society)
- Author
-
Julie Park
250. Reproducing Samoans In Auckland 'In Different Times': Can Habitus Help (Journal of the Polynesian Society)
- Author
-
Julie Park and Carolyn Morris
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.